United States · FDA National Drug Code directory

Topiramate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 70748-276_68180c67-ab30-49d0-aece-5a8d476097e2
Product NDC: 70748-276
Form: CAPSULE, EXTENDED RELEASE
Composition / generic term: Topiramate
Labeler: Lupin Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20260203
Source listing expiry: 20271231

Source-listed ingredients

TOPIRAMATE — 50 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70748-276-06) · 70748-276-06

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →